The two makers of messenger RNA vaccines are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant increase demand, and the companies raise prices.
As Covid-19 Boosters Loom, Pfizer, Moderna to See Billions More in Sales
Wall Street Journal - 19 Aug 2021 14:00
The two makers of messenger RNA vaccines are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant increase demand, and the companies raise prices.
Share this Article
Recommended